Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Andina Bottling (AKO-B) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Andina Bottling (AKO-B) over the last 15 years, with Q4 2025 value amounting to $296.5 million.

  • Andina Bottling's Cash & Equivalents rose 1914.06% to $296.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $296.5 million, marking a year-over-year increase of 1914.06%. This contributed to the annual value of $296.5 million for FY2025, which is 1914.06% up from last year.
  • Per Andina Bottling's latest filing, its Cash & Equivalents stood at $296.5 million for Q4 2025, which was up 1914.06% from $282.8 million recorded in Q3 2025.
  • Andina Bottling's Cash & Equivalents' 5-year high stood at $389.7 million during Q1 2022, with a 5-year trough of $207.2 million in Q2 2025.
  • Its 4-year average for Cash & Equivalents is $263.2 million, with a median of $254.1 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 3347.63% in 2023, then skyrocketed by 3424.18% in 2025.
  • Andina Bottling's Cash & Equivalents (Quarter) stood at $291.7 million in 2022, then rose by 4.11% to $303.7 million in 2023, then dropped by 18.04% to $248.9 million in 2024, then grew by 19.14% to $296.5 million in 2025.
  • Its Cash & Equivalents stands at $296.5 million for Q4 2025, versus $282.8 million for Q3 2025 and $207.2 million for Q2 2025.